AVITA Medical, Inc. (RCEL)
NASDAQ: RCEL · IEX Real-Time Price · USD
8.52
+0.22 (2.65%)
At close: Apr 26, 2024, 4:00 PM
8.91
+0.39 (4.58%)
After-hours: Apr 26, 2024, 6:08 PM EDT

AVITA Medical Revenue

In the year 2023, AVITA Medical had annual revenue of $51.57M with 37.03% growth. Revenue in the quarter ending December 31, 2023 was $14.25M with 36.00% year-over-year growth.

Revenue (ttm)
$51.57M
Revenue Growth
+37.03%
P/S Ratio
4.26
Revenue / Employee
$249,135
Employees
207
Market Cap
219.81M USD

Revenue Chart

* The company reports in AUD currency but revenue data is shown in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202351.57M13.94M37.03%
Dec 31, 202237.64M3.02M8.73%
Dec 31, 202134.62M16.43M90.31%
Jun 30, 202018.19M6.79M59.62%
Jun 30, 201911.40M2.73M31.54%
Jun 30, 20188.66M3.53M68.74%
Jun 30, 20175.13M3.33M184.18%
Jun 30, 20161.81M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Auna S.A. 1.04B
Accuray 447.48M
uniQure 15.84M
Lineage Cell Therapeutics 8.95M
Adlai Nortye 5.00M
Century Therapeutics 2.24M
Ovid Therapeutics 391.70K
Revenue Rankings